Abstract
A high cytoplasmic Na+ concentration may contribute to N-methyl-d-aspartate (NMDA)-induced excitotoxicity by promoting Ca2+ influx via reverse operation of the Na+/Ca2+ exchanger (NaCaX), but may simultaneously decrease the electrochemical Ca2+driving force by depolarizing the plasma membrane (PM). Digital fluorescence microscopy was used to compare the effects of Na+ versus ions that do not support the NaCaX operation, i.e., N-methyl-d-glucamine+ or Li+, on: PM potential; cytoplasmic concentrations of Ca2+, H+, and K+; mitochondrial Ca2+ storage; and viability of primary cultures of cerebellar granule cells exposed to NMDA receptor agonists. In the presence of Na+ or Li+, NMDA depolarized the PM and decreased cytoplasmic pH (pHC); in the presence of Li+, Ca2+ influx was reduced, mitochondrial Ca2+ overload did not occur, and the cytoplasm became more acidified than in the presence of Na+. In the presence ofN-methyl-d-glucamine+, NMDA instantly hyperpolarized the PM, but further changes in PM potential and pHC were Ca-dependent. In the absence of Ca2+, hyperpolarization persisted, pHC was decreasing very slowly, K+ was retained in the cytoplasm, and cerebellar granule cells survived the challenge; in the presence of Ca2+, pHC dropped rapidly, the K+concentration gradient across the PM began to collapse as the PM began to depolarize, and Ca2+ influx and excitotoxicity greatly increased. These results indicate that the dominant, very likely excitotoxic, component of NMDA-induced Ca2+ influx is mediated by reverse NaCaX and that direct Ca2+ influx via NMDA channels is curtailed by Na-dependent PM depolarization.
Footnotes
- Received December 7, 1998.
- Accepted June 9, 1999.
-
Send reprint requests to: Lech Kiedrowski, Ph.D., The Psychiatric Institute, 1601 W. Taylor St., Chicago, IL 60612. E-mail:lkiedr{at}psych.uic.edu
-
This work was supported in part by National Institutes of Health Grant NS 37390 and presented in part in abstract form, Society of Neuroscience Abstracts 300.5, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|